Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Frontiers in Oncology|December 29, 2025
The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differencesByeongsang Oh, Gillian Lamoury, Susan Carroll, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcomeNigel Spry, Jennifer Harvey, Craig Macleod, et al.International Journal of Cancer|February 6, 2014
Human papillomavirus (HPV) genotypes in an Australian sample of anal cancersRichard J Hillman, Suzanne M Garland, Manoji P W Gunathilake, et al.Inflammatory Bowel Diseases|March 11, 2011
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviorGary R Lichtenstein, Stephan R Targan, Marla C Dubinsky, et al.Journal of Medical Radiation Sciences|August 13, 2021
Comprehensive nodal breast VMAT: solving the low-dose wash dilemma using an iterative knowledge-based radiotherapy planning solutionCameron Stanton, Linda J Bell, Andrew Le, et al.Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.Advances in Radiation Oncology|September 2, 2024
Prospective Randomized Trial Comparing 2 Devices for Deep Inspiration Breath Hold Management in Breast Radiation Therapy: Results of the BRAVEHeart TrialHilary L Byrne, Elisabeth Steiner, Jeremy Booth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapyBertrand Coiffier, Barbara Pro, H Miles Prince, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.Pageof 9